A therosclerosis is a highly dynamic 1,2 metabolic disease with a strong inflammatory component. [3] [4] [5] Compelling evidence, largely based on data derived from murine models of atherosclerotic disease, implies extensive involvement of the adaptive immune response in the initiation, progression, and complications of atherosclerotic disease. 6 As a consequence, the adaptive immune response is considered a potential target for medical interventions. An open question is how these observations translate to the human situation. There are fundamental immunological and inflammatory differences between mice and humans. [7] [8] [9] Moreover, murine models of accelerated atherosclerotic disease require an immunologic background with exaggerated Th1-cell responsiveness in order for atherosclerosis to develop. 8, 9 Hence, observations from mouse models may be skewed toward Th1 response. Extrapolation of the murine data is further complicated by absence of vulnerable lesion formation in the current models of atherosclerotic disease. As a result, data on a possible involvement of the adaptive immune response in the advanced stages of atherosclerotic disease are missing. Available human data, on the other hand, largely rely on surgical specimens. Yet, it is important to note that this material generally represents the final stages of the disease process. 10, 11 As such, data from these human studies are not representative for the earlier and intermediate phases of atherosclerotic disease; hence, knowledge of the nature of the adaptive immune response in the human atherosclerotic process is limited. Given the above considerations, we regarded an evaluation of the adaptive immune response within the process of atherosclerotic lesion formation, progression, and stabilization to be relevant. To that end, we performed comprehensive and systematic histological assessment of cellular aspects of the adaptive immune response in tissue samples from a biobank of arterial tissue that covers the full spectrum of human atherosclerotic disease. Results from this explorative study confirm an extensive and dynamic presence of cellular components of the adaptive immunity in the human atherosclerotic process, and reveal profound changes in the inflammatory footprint immediately prior to and during the process of plaque destabilization.
Materials and Methods

Patients and Tissue Sampling
Tissue sections were selected from a tissue bank of aortic wall patches that were obtained during liver, kidney, and Figure 1 . Example of the regions of interest as used for the assessment of immunolocalization of T cells (and T-cell subset), B cells, and plasma cells in a healed rupture. The regions of interest are drawn in the fibrous cap, in 1 of the shoulders and 3 times in the media in this particular example. For every lesion (normal or ruptured), a total of 9 images were made (3 in the intima, 3 in the media, and 3 in the adventitia) and the immunostaining was quantitatively assessed with an image-processing program (Image J; plug-in Cellcounter). pancreas transplantation with grafts derived from cadaveric donors. Details of this bank have been described previously by van 
Immunohistochemistry
All specimens used for immunohistochemistry (IHC) were washed in PBS, formalin fixed, and decalcified (Kristensens solution), and paraffin embedded using standard procedures. The details of the antibodies used for IHC are listed in Table 2 . Conjugated biotinylated horse anti-mouse (1:400 dilution; Vector laboratories, Amsterdam, the Netherlands) or Envi- sion+ System-horseradish peroxidase-labeled polymer antimouse/anti-rabbit (prediluted; Dako, Heverlee, Belgium) functioned as secondary antibodies. Sections were developed with Nova Red or DAB and counterstained with Mayer's hematoxylin or methyl green. Positive and negative controls were always included and performed by adding or omitting the primary antibody on 3-aminopropyltriethoxysilane slides containing human tonsils. The Foxp3/CD3 and interleukin-17/CD3 double staining was performed to identify regulatory T cells and Th17 cells, respectively (Table 1) . Conjugated polymer anti-mouse/antirabbit (Immunologic) functioned as secondary antibodies. After the goat-derived anti-interleukin-17 incubation, a rabbit anti-goat secondary antibody (Southern Biotech, Birmingham, AL) served as a bridge reagent for the next step with alkaline phosphatase anti-rabbit polymer (Immunologic, Duiven, the Netherlands). All immunohistochemical stainings were performed as previously described.
14 Despite many attempts and various techniques, we did not succeed in using GATA-3 as the T-helper 2 marker. We therefore had to turn to double staining for CD4/Tbet to identify the T-helper lineage (Lineage: Th1=CD4 + /Tbet + and non-Th1=CD4 + /Tbet À ) having regard to the provision that non-Th1 may also include Th0, Th17, and Th22 populations.
Assessment of Immunolocalization of T Cells (and T-Cell Subset), B Cells, and Plasma Cells
The tissue block showing the most advanced plaque was used for further studies. When the aortic sample contained more than 1 lesion, the most advanced lesion on the slide was used. The lesion was defined as the area between the endothelium and the first elastic lamina over a distance of 1 mm. In the presence of a necrotic core, the distance was expanded with another 500 lm on both sides of the necrotic core to include the adjacent shoulder region. 12 The regions of interest were the intima (and in the presence of an early or late necrotic core, the intima was divided into a cap and both shoulder regions), the media, and the adventitia ( Figure 1 ). Within the regions of interest (ie, intima, media, and adventitia), 3 representative adjacent images were made at a 9200 magnification. A total of 9 images per atherosclerotic lesion were separately analyzed from the lesion. Immunostaining intensity was quantitatively assessed with an imageprocessing program (Image J; plug-in Cellcounter). Representative examples of the immunological stainings are provided in Figure 2 .
Statistical Analysis
Data in figures are presented as meanAESEM. Spearman's correlation was used to demonstrate the relationship between the amount of positive cells in the intima, media, and adventitia within 1 phase of the atherosclerotic disease and compared with the previous and/or next + cells (white arrow) were seen in the adventitia that, as previous studies showed, can be addressed to macrophages. 15 A human tonsil (not associated with the aortic biobank) functioned as a positive control for the CD3/IL17 staining and showed numerous Th17 cells. Ferangi blue was used to develop CD3 and alkaline phosphatase for FoxP3 and IL17. The solid bars represent the number of FoxP3 + T cells within the various layers of the aorta per stage of atherosclerosis. Total number of cases: 97 (N [9] , AIT [9] , IX [11] , PIT [11] , EFA [10] , LFA [9] , TCFA [9] , PR [10] , HR [8] and FCP [11] ). For a detailed description concerning the classification, see the Materials and Methods section. All images were taken at a 9400 magnification. AIT indicates adaptive intimal thickening; EFA, early fibroatheroma; FCP, fibrotic calcified plaque; HR, healed plaque rupture; IX, intimal xanthoma; LFA, late fibroatheroma; N, normal; PIT, pathological intimal thickening; PR, acute plaque rupture; TCFA, thin-cap fibroatheroma.
the mean total number of cells within each atherosclerotic phase, and the Kruskal-Wallis test was used to control for a type 1 error. A value of P<0.05 was considered statistically significant.
Results
Studied Population
Characteristics of the studied population are provided in Table 1 . The male/female ratio was evenly distributed (57% male), as was the mean age for each sex (%49 years). There was a strong correlation between donor age and atherosclerosis progression 12 ( Table 3 ). The mean donor age for the aortic wall samples classified as normal was 23 years, whereas the mean age for aortas with fibrotic calcified plaques, representing the final stage of the disease, was 62 years. Nearly 40% of patients had a known history of smoking, and 2 patients received statin therapy. Twenty-three patients had a known history of hypertension; 17 of these patients received antihypertensive medication. 
P<0.0001). Total number of cases in (A) and (B)
: 95 (N [9] , AIT [9] , IX [11] , PIT [12] , EFA [9] , LFA [8] , TCFA [9] , PR [10] , HR [7] , and FCP [11] ). C, The intima remains practically devoid of CD4 + T cells up until late fibroatheroma. There is a significant increase of T-helper cells in vulnerable lesions compared to PIT, EFA, and LFA followed by a significant decrease in stabilizing lesions (*P<0.008; † P<0.004). [9] , IX [11] , PIT [11] , EFA [8] , LFA [10] , TCFA [9] , PR [9] , HR [7] and FCP [9] ). E, Cytotoxic T cells are more abundantly present in the intima in the progressive stages of atherosclerosis (*P<0.001) when compared to normal, AIT and IX. The media and adventitia show an increasing number of cytotoxic T cells within progressive atherosclerotic lesions (PIT, EFA, and LFA) compared to the prior phases followed by a significant rise within the vulnerable plaques and a significant decrease as the lesions stabilize ( † P<0.0001; ‡ P<0.0001; § P<0.0001; and ‫װ‬ P<0.0001). F, The total number of cytotoxic T cells follows a similar pattern to that of the T-helper lineage in (B): a significant increase within progressive and vulnerable lesions followed by a decrease in stabilized lesions (*P<0.002; † P<0.0001, and ‡ P<0.0001). Total number of cases in (E) and (F): 96 (N [9] , AIT [9] , IX [10] , PIT [12] , EFA [10] , LFA [10] , TCFA [9] , PR [10] , HR [8] and FCP [9] ). The vertical axis of (A), (C), and (E) is presented as a log-scale. 
The Vulnerable Lesions
Thin-cap fibroatheromas and ruptures are hallmarked by a peak in T-cell infiltration in the adventitia underneath the culprit lesion (Figures 3 through 9 (Figure 10) . A unique finding in the vulnerable lesions is the appearance of B cells and occasional plasma cells in tertiary folliclelike structures. Staining for CXCL13, a homeostatic, lymphorganogenic chemokine that is critical for organization of folliclelike structures, shows CXCL13 expression exclusively in vulnerable lesions (viz, no CXCL13 staining was found in the other stages of the disease) and reveals a particular staining pattern of a dendritic network with extension from the follicles (Figure 9 ). Additional staining A Figure 6 . Number of Thelper1 and non-Thelper1 cells within the various layers of the aortic wall. A, There is a gradual increase in Thelper1 cells in the intima and adventitia with advancing atherosclerotic lesions. An increase is seen in the amount of Thelper1 cells within ruptured plaques; note the fact that these cells are mainly located in the adventitia. Total number of cases in (A): 97 (N [9] , AIT [9] , IX [11] , PIT [11] , EFA [12] , LFA [8] , TCFA [12] , PR [8] , HR [9] and FCP [8] ). B, There are far more non-Thelper1 cells within the aortic wall compared to the number of Thelper1 cells. However, the same gradual increase in number is seen as the atherosclerotic lesions progress toward the vulnerable thin-cap fibroatheroma. Again, an increase is seen within ruptured plaques. Total number of cases in (B): 98 (N [8] , AIT [10] , IX [11] , PIT [10] , EFA [12] , LFA [9] , TCFA [12] , PR [8] , HR [10] and FCP [8] ). C, Illustrative images of the adventitia adjacent to the intimal plaque in the various stages of the atherosclerotic process with CD4/Tbet double-staining corresponding with the presented graphs (A and B). [9] , IX [12] , PIT [11] , EFA [9] , LFA [9] , TCFA [9] , PR [10] , HR [7] and FCP [10] ). AIT indicates adaptive intimal thickening; EFA, early fibroatheroma; HR, healed rupture; FCP, fibrotic calcified plaque; IX, intimal xanthoma; LFA, late fibroatheroma; N, normal; PIT, pathological intimal thickening; PR, plaque rupture; TCFA, thin-cap fibroatheroma. For a detailed description concerning the classification, see the Materials and Methods section. All images were taken at 9400 magnification. the media and adventitia remains stable. Native T-cell numbers are highly variable. The folliclelike structures vanish and CXCL13 disappeared from the arterial wall. No regulatory T cells or Th17 cells are detected in the stabilized lesions.
Discussion
A wealth of preclinical evidence supports a critical role of the adaptive immunity in the initiation and progression of atherosclerosis. 17, 18 This study, based on histological observations in human aorta sections, confirms extensive and progressive involvement of cellular components of the adaptive immune response in atherosclerosis. 19 Findings point to profound changes in the nature of the response in the lead-up to plaque destabilization and show extinguishing of inflammatory processes upon plaque stabilization. This study reveals fundamental differences between the human atherosclerotic disease and mouse models of the disease, particularly with respect to a very limited presence of regulatory T cells, absence of Th17 cells throughout the atherosclerotic process, and lack of B cells in the early-, intermediate-, and final stages of the process. Insight into the atherosclerotic process greatly depends on observations from murine models of the disease. 20 Indeed, genetically modified mouse models have been critical for [9] , AIT [9] , IX [11] , PIT [11] , EFA [10] , LFA [9] , TCFA [9] , PR [10] , HR [8] , and FCP [11] ). AIT indicates adaptive intimal thickening; EFA, early fibroatheroma; HR, healed rupture; FCP, fibrotic calcified plaque; IX, intimal xanthoma; LFA, late fibroatheroma; N, normal; PIT, pathological intimal thickening; PR, plaque rupture; TCFA, thin-cap fibroatheroma. For a detailed description concerning the classification, see the Materials and Methods section. All images were taken at 9400 magnification.
understanding the atherosclerotic process. Yet, by virtue of the metabolic adaptations in the lipoprotein metabolism, necessary to induce atherosclerotic lesion formation, the process in these animals is essentially lipid driven (a situation that may not fully mimic the human situation). 21, 22 Translation of rodent findings is further obscured by critical dependence on genetic backgrounds with Th1-dominated immune responses in order for atherosclerosis to develop; by the fundamental and intrinsic differences in inflammatory and immune responses between mice and humans; and by failure of the experimental lesions to progress to culprit lesions (vulnerable plaque) formation. 7, 23, 24 Consequently, information provided by these models may be biased, and is incomplete at least with respect to vulnerable lesions. As a result, the preclinical observations may not directly translate to the human situation. 8, 9 Data on human atherosclerosis are also limited, a situation largely reflecting the fact that most observations are made on material obtained during surgical procedures (eg, endarterectomy). This material typically represents the final stage(s) of the disease and, in the case of an endarterectomy material, will not provide information on the outer media and the adventitia, both major interphases in vessel wall inflammation. With this in mind, we set up a biobank of aortic wall [9] , AIT [9] , IX [11] , PIT [11] , EFA [10] , LFA [9] , TCFA [9] , PR [10] , HR [8] , and FCP [11] ). C, An adventitial follicle in a thin-cap fibroatheroma consecutively stained for CD20, CD21, and CXCL13. Notice the abundance of (CD21-negative) B cells clustered around the CXCL13 positive radiating pattern of tubelike structures. Antiactivation-induced cytidine deaminase (AID) stained negative within the adventitial infiltrates. Due to the disturbing amount of background staining, a high-resolution image of a positive control for the anti--AID staining in a human tonsil is provided to illustrate the mature B cell. All images were taken at 9400 magnification. All sections were developed with Diaminobenzidine (DAB) and counterstained with Mayer's hematoxylin. The vertical axis is presented as a log-scale. The solid bars represent the number of CD20 + B cells or CD138 + plasma cells within the various layers of 1 aortic plaque. AIT indicates adaptive intimal thickening; EFA, early fibroatheroma; HR, healed rupture; FCP, fibrotic calcified plaque; IX, intimal xanthoma; LFA, late fibroatheroma; N, normal; PIT, pathological intimal thickening; PR, plaque rupture; TCFA, thin-cap fibroatheroma. For a detailed description concerning the classification, see the Materials and Methods section.
samples from organ grafts designated for transplantation. Material from this bank almost covers the full life span (5 to 80 years) and shows a nearly equal sex distribution. The relatively healthy premortal status of the donors is reflected by minimal use of statins and antihypertensive drugs. Classification was done for all individual tissue sections in the bank (viz, each individual tissue block was Movat and hematoxylin stained, and histologically staged using an established adapted version of the AHA classification system). 12, 13 Modifications in the adapted classification system highlight specific critical morphological events in the final stages of the disease process. This allows for a more precise interpretation of processes occurring during plaque destabilization and subsequent healing. An earlier systematic evaluation of material in the biobank showed that the bank covers the full spectrum of atherosclerotic disease. 12 Exact morphologic descriptions and examples of the different lesions have been published and discussed previously.
12
Immunohistochemical staining for CD3, CD4, and CD8 shows progressive T-cell accumulation during the atherosclerotic process. The earlier phases are dominated by diffuse cytotoxic T-cell infiltration, but progressive quantities of T-helper cells are found during progression of the disease, resulting in an increase in the CD4 + /CD8 + T-cell ratio during disease progression. These observations are in line with an earlier report on renal artery atherosclerosis, and with observations from other progressive inflammatory disorders. 25, 26 Due to inherent limitations of paraffinembedded tissue, we were unable to test whether these shifts reflect an (auto)immune phenomenon, as has been proposed in the context of advanced atherosclerotic disease. 27, 28 CD4/T-Bet double staining was used to identify Th1 cells. T-bet is the lineage-defining transcription factor for Th1 cells. 29 In the absence of Th17 and with minimal regulatory T cells throughout the atherosclerotic spectrum, we defined the CD4+/T-bet-negative cells as non-Th1 cells. Quantification of the Th1/non-Th1 ratio on the basis of the CD4/T-Bet double staining did not confirm Th1 dominance in the human atherosclerotic process. This may indicate that the presumed Th1 dominance in atherosclerosis reflects an artificial phenomenon related to the requirement of Th1-dominated backgrounds in mouse models in order for atherosclerosis to develop. Yet, alternative explanations are that identification based on T-Bet positivity underestimates the number of Th1 cells or, vice versa, that identification based on cytokine profiles overestimates the number of Th1 cells. 30 Findings for the CD45RO (T-memory cells) and CD45RA (na€ ıve T cells) largely follow observations for other solid organs (predominance of T-memory cells) and extend those made in rodent models of atherosclerotic disease showing increasing T-cell infiltration during disease progression, with a clear maximum during plaque destabilization followed by a rapid decline during plaque stabilization (plaque healing). 31 A remarkable and novel observation is the change in the inflammatory footprint that accompanies plaque destabilization, and that fully resolves during plaque stabilization. This change appears to precede plaque destabilization, and is confined to the area adjacent to the culprit lesion. On the cellular level, this change is characterized by a sharp increase in the number of T-helper cells, emergence of na€ ıve T-cells, and the appearance of B cells and occasional plasma cells in tertiary folliclelike structures. B cells in the follicles are largely activation-induced cytidine deaminase and CD21 negative, indicating gross absence of B-cell maturation. 32, 33 These observations suggest that signals promoting B-cell homing and follicle assembly accompany (and may even precede) plaque destabilization, but that essential signals critical for maturation of B cells are missing.
The chemokine CXCL13 is a pivotal homeostatic signal for follicle formation. 34, 35 As for the appearance of folliclelike structures, we performed immunostaining for CXCL-13 and observed CXCL-13 expression exclusively in association with the folliclelike structures in the vulnerable lesions (viz, CXCL-13 was not detected in the other stages of the disease). CXCL13 distribution shows a remarkable radiating pattern of tubelike structures that may reflect expression in dendritic cells. 36 In light of the remarkable association between CXCL13 and plaque instability, we tested an association between plasma CXCL13 levels and acute cardiovascular events (acute myocardial infarction) in plasma samples of the Mission study. 36 CXCL13 was largely undetectable, and no association was found between CXCL-13 and cardiovascular events (results not shown). Absence of such an observation may reflect the highly localized character of CXCL13 expression in the vulnerable lesion. B cells are considered critical players in the atherosclerotic process, albeit their role (protective, detrimental) is still under debate. 37, 38 Our findings of a very restricted presence of B cells in human atherosclerosis follow observations from Frosteg ard et al 39 Hence, these findings and gross absence of signs of B-cell maturation in the infiltrating B cells exclude an autocrine or paracrine role of B cells in the human atherosclerotic process. Yet, humoral factors released by B cells in paravascular lymph nodes or more distant locations may well be involved in the disease process. Regulatory T cells were incidentally found in a subset of the vulnerable lesions, whereas Th17 cells were fully absent in the aortic sections. This latter observation follows results of a comprehensive analysis of cytokines in atherosclerotic wall samples that failed to detect interleukin-17 in all samples tested (detection threshold of the assay <1 pg/L). 40 Although these observations do not exclude a distant role for these cell populations, they seem to contradict observations from murine models implying these cells as local key-players in the atherosclerotic process.
Limitations
This study was performed on aortic sections of deceased individuals, as such the continuous data in this study are composed of incidental findings from a large series of patients and therefore may not necessarily reflect longitudinal data. Another limitation of the study is the fact the all findings are based on IHC using paraffin-embedded tissue sections. Although IHC has the advantage of showing the spatial relationships, multiple stainings are elaborative, and only allow for very limited marker sets. Consequently, findings in this study should be considered at a global level. That is, the apparent mismatch between the total number of CD3 counts and the sum of CD4 and CD8 may reflect abundance of other CD3-expressing populations such as NK and NK-T cells but also reflect technical limitations of IHC with different epitope availabilities and antibody efficacies. Yet, it is likely that the latter phenomena would equally apply to all tissue sections, and it is thus unlikely that this would influence the conclusions of the study.
In conclusion, this study shows clear changes in the cellular components of the adaptive immune system in anticipation of and during plaque destabilization. Observations suggest that changes in the inflammatory footprint precede and accompany plaque instability. It is tempting to speculate that delineation of this chain of events may provide clues for early culprit lesion detection and plaque stabilization.
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